Stock Yards Bank & Trust Co. lessened its holdings in shares of Aflac Incorporated (NYSE:AFL – Free Report) by 8.1% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 4,680 shares of the financial services provider’s stock after selling 410 shares during the period. Stock Yards Bank & Trust Co.’s holdings in Aflac were worth $520,000 at the end of the most recent reporting period.
Other institutional investors have also modified their holdings of the company. Roxbury Financial LLC bought a new stake in shares of Aflac during the 4th quarter valued at about $948,000. Proficio Capital Partners LLC bought a new stake in shares of Aflac during the 4th quarter valued at about $192,000. Next Level Wealth Planning LLC bought a new stake in shares of Aflac during the 4th quarter valued at about $318,000. Blue Trust Inc. grew its position in Aflac by 872.3% in the 4th quarter. Blue Trust Inc. now owns 187,997 shares of the financial services provider’s stock worth $19,446,000 after purchasing an additional 168,661 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC grew its position in Aflac by 39.9% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 64,399 shares of the financial services provider’s stock worth $6,592,000 after purchasing an additional 18,366 shares during the last quarter. Institutional investors own 67.44% of the company’s stock.
Insider Activity at Aflac
In related news, Director Masatoshi Koide sold 37,000 shares of the stock in a transaction that occurred on Tuesday, May 20th. The shares were sold at an average price of $105.59, for a total transaction of $3,906,830.00. Following the completion of the sale, the director now directly owns 70,992 shares of the company’s stock, valued at $7,496,045.28. This represents a 34.26% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Arthur Reginald Collins sold 2,750 shares of the stock in a transaction that occurred on Thursday, May 15th. The shares were sold at an average price of $105.70, for a total transaction of $290,675.00. Following the sale, the director now directly owns 6,728 shares of the company’s stock, valued at approximately $711,149.60. This represents a 29.01% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 40,750 shares of company stock valued at $4,304,295 over the last ninety days. Insiders own 0.90% of the company’s stock.
Aflac Trading Down 0.6%
Aflac (NYSE:AFL – Get Free Report) last released its earnings results on Wednesday, April 30th. The financial services provider reported $1.66 EPS for the quarter, missing the consensus estimate of $1.67 by ($0.01). Aflac had a net margin of 28.76% and a return on equity of 16.20%. The business had revenue of $3.40 billion for the quarter, compared to analyst estimates of $4.53 billion. During the same period in the prior year, the company earned $1.66 earnings per share. The firm’s revenue for the quarter was down 37.5% on a year-over-year basis. As a group, analysts anticipate that Aflac Incorporated will post 6.88 earnings per share for the current fiscal year.
Aflac Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Monday, June 2nd. Investors of record on Wednesday, May 21st were paid a dividend of $0.58 per share. This represents a $2.32 annualized dividend and a yield of 2.27%. The ex-dividend date was Wednesday, May 21st. Aflac’s dividend payout ratio is presently 36.25%.
Analyst Ratings Changes
Several research analysts have commented on AFL shares. Raymond James decreased their target price on shares of Aflac from $115.00 to $110.00 and set an “outperform” rating for the company in a research report on Thursday, May 29th. Morgan Stanley upped their target price on shares of Aflac from $100.00 to $105.00 and gave the stock an “equal weight” rating in a research report on Monday, May 19th. Piper Sandler upped their target price on shares of Aflac from $118.00 to $124.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 2nd. UBS Group upped their target price on shares of Aflac from $109.00 to $114.00 and gave the stock a “neutral” rating in a research report on Wednesday, April 2nd. Finally, JPMorgan Chase & Co. upped their target price on shares of Aflac from $94.00 to $96.00 and gave the stock a “neutral” rating in a research report on Wednesday, April 2nd. Three investment analysts have rated the stock with a sell rating, ten have given a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $104.93.
Read Our Latest Stock Report on AFL
Aflac Profile
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Featured Articles
- Five stocks we like better than Aflac
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Synopsys Stock Falls on China Ban, But Long-Term Outlook Holds
- What is Forex and How Does it Work?
- Alphabet Enters a Bull Market: Is It Time to Buy?
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Ouster Soars 27% as DoD Grants First 3D LiDAR Approval for Drones
Want to see what other hedge funds are holding AFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aflac Incorporated (NYSE:AFL – Free Report).
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.